欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (12): 1675-1682.doi: 10.12092/j.issn.1009-2501.2025.12.011

• 基础研究 • 上一篇    下一篇

ELISA法对大鼠血清中HLX43药代动力学的探索性研究

刘嘉豪1,张二辉2,刘晓平1   

  1. 1皖南医学院,芜湖  241002,安徽;2上海佐临生物科技有限公司,上海  201600
  • 收稿日期:2024-01-29 修回日期:2024-06-08 出版日期:2025-12-26 发布日期:1900-01-01
  • 通讯作者: 刘晓平,通信作者,男,博士,研究方向:药理学。 E-mail: liuxiaoping @wnmc.edu.cn 张二辉,通信作者,男,硕士,研究方向:定量药理学。 E-mail: Eric_Zhang@jollinlab.com
  • 作者简介:刘嘉豪,男,在读硕士研究生,研究方向:药代动力学研究。 E-mail: 1787168655@qq.com

Pilot study on pharmacokinetics of HLX43 in rat serum by ELISA

LIU Jiahao1, ZHANG Erhui2, LIU Xiaoping1   

  1. 1 Wannan Medical College, Wuhu 241002, Anhui, China; 2 Shanghai Jollin Lab Co., Ltd., Shanghai 201600, China
  • Received:2024-01-29 Revised:2024-06-08 Online:2025-12-26 Published:1900-01-01

摘要:

目的:以酶联免疫吸附试验(ELISA)为基础建立可快速检测大鼠血清中的抗体偶联药物HLX43结合抗体以及总抗体的分析方法,并用来探索大鼠单次静脉注射给药的药代动力学特征。方法:以 ELISA 的检测原理为基础,在96孔板上包被Goat anti-Human IgG(检测总抗体)或Anti-payload antibody(检测结合抗体),加入待测样品,用Goat anti-human IgG Monkey ads-HRP作为检测抗体进行检测,加入TMB底物显色一段时间后,加入终止液中止反应,使用酶标仪SoftMax软件在双波长450 nm/630 nm下读取吸收度,采用 A450 nm-A630 nm 读值进行数值拟合,参考相关法规要求进行初步验证后,SD大鼠静脉注射15 mg/kg  HLX43取血检测血药浓度,并计算药代动力学参数。结果:确定分析方法的线性范围为200~6 000 ng/mL,对分析方法的标准曲线、精密度、准确度、钩状效应、稀释线性以及选择性(基质效应)的考察结果均可接受。对SD大鼠血清样品进行定量分析,得到HLX43的药代动力学参数,检测结合抗体和检测总抗体的方法所得出的t1/2分别为110.9 h和110.6 h,Cmax分别为343.3 μg/mL和386.3 μg/mL,AUC0-inf分别为13 977.511 h·μg·mL-1和16 916.523 h·μg·mL-1。结论:本研究建立了两种快速灵敏的方法用于HLX43的药动学研究,为抗体偶联药物的临床研究奠定了基础。

关键词: 酶联免疫吸附分析(ELISA), 定量测定, 抗体偶联药物, 药代动力学

Abstract:

AIM: To establish a method for rapid detection of HLX43 conjugated  antibody and total antibody in rat serum based on enzyme-linked immunosorbent assay (ELISA), and to explore the pharmacokinetic characteristics of single intravenous injection in rats. METHODS: Based on the detection principle of ELISA, Goat anti-Human IgG (detecting total antibody) or Anti-payload antibody (detecting conjugated antibody) was coated on a 96-well plate, and the sample to be tested was added. Goat anti-human IgG Monkey ads-HRP was used as a detection antibody for detection. After adding TMB substrate for color display for a period of time, the reaction was quenched by adding stop solution. The absorption(A) was read at double wavelength 450 nm/630 nm by using SoftMax. Reading values of A450 nm-A630 nm were used for numerical fitting, and after preliminary verification based on relevant regulatory requirements, SD rats were intravenously injected 15 mg/kg HLX43 to take blood for detection of drug concentration, and pharmacokinetic parameters were calculated. RESULTS: The linear range of the analytical method was 200-6 000 μg/mL, and the results of standard curve, precision, accuracy, hook effect, dilution linearity and selectivity (matrix effect) of the analytical method were acceptable. The pharmacokinetic parameters of HLX43 were determined by quantitative analysis of serum samples from SD rats. The t1/2 was 110.9 h for conjugated antibody and 110.6 h for total antibody , respectively, Cmax was 343.3 μg/mL and 386.3 μg/mL respectively, AUC0-inf was 
13 977.511 h·μg·mL-1 and 16 916.523 h·μg·mL-1, respectively. CONCLUSION: This study developed two rapid and sensitive methods for the pharmacokinetic study of HLX43, laying the foundation for clinical research on adcs.

Key words: enzyme-linked immunosorbent assay (ELISA), quantitative determination, antibody-drug conjugate, pharmacokinetics ,   

中图分类号: